hrp0097fc8.6 | Fat, metabolism and obesity 2 | ESPE2023

Liraglutide treatment in adolescents with extreme obesity - Effects on weight loss in the first 9 months under real-life conditions

Schirmer Melanie , Brandt Stephanie , Knupfer Magdalena , Zorn Stefanie , Weihrauch-Blüher Susann , Wabitsch Martin

Introduction: The Glucagon-like Peptide(GLP1)-analogue liraglutide is the first drug approved for the treatment of obesity in adolescents in Europe. While clinically relevant effects of liraglutide treatment in adolescents with obesity had been shown in a phase III study, there are no reports about the use under real-life conditions in these patients. Our aim was to report the effect of treatment with liraglutide on body weight loss in a cohort of adolescents ...

hrp0097rfc3.6 | Fat, metabolism and obesity 1 | ESPE2023

Glucocorticoid-mediated leptin secretion from human adipocytes is dependent on glucose availability

Tews Daniel , Brandt Stephanie , von Schnurbein Julia , Fischer-Posovszky Pamela , Wabitsch Martin

Background: Leptin is produced by adipocytes and regulates central hunger and satiety sensation. While the central leptin effects are well understood, little is known about the regulation of peripheral leptin production. Clinical data demonstrate that leptin levels are rapidly declining upon fasting, suggesting that leptin secretion is acutely regulated by nutrient availability. Although it has been previously shown that leptin secretion is under control by gl...

hrp0097p1-367 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023

Changes in body composition in transgender adolescents during puberty suppression and hormone treatment

Boogers Lidewij , Reijtenbagh Sterre , Wiepjes Chantal , van Trotsenburg Paul , den Heijer Martin , Hannema Sabine

Context: Transgender adolescents can be treated with puberty suppression (PS) using GnRH agonists (GnRHa), and subsequent hormone therapy (HT). Up to this date, it has not been described at what rate body composition in transgender adolescents changes during the first years of treatment. Also, it is unknown whether Tanner stage at which treatment is initiated, might affect this treatment outcome.Methods: Transgender adol...

hrp0098fc5.1 | Growth and Syndromes | ESPE2024

A homozygous variant in ZSWIM6 causes short stature, microcephaly and developmental delay

Anne Amaratunga Shenali , Bezdicka Martin , Hussein Tayeb Tara , Soucek Ondrej , Lebl Jan

Introduction: The ZSWIM6 gene was first described with a unique de-novo heterozygous variant causing acromelic frontonasal dysostosis, characterized by craniofacial, brain, and limb malformations. Another de-novo heterozygous variant was later described causing severe intellectual disability, hypotonia amd seizures but without craniofacial or limb malformations. These findings suggest a clear genotype-phenotype correlation for ZSWIM6. Gene in...

hrp0098fc6.3 | Fat, Metabolism and Obesity 1 | ESPE2024

SPISE is more strongly correlated with cardiometabolic factors in adolescents with obesity than HOMA-IR, and is related to the amount of body weight reduction under lifestyle intervention

Tantari Giacomo , Brandt-Heunemann Stephanie , Maghnie Mohamad , Siegfried Wolfgang , Denzer Christian , Wabitsch Martin

Introduction: Impaired insulin sensitivity (IS) is a hallmark of increased cardiometabolic risk in adolescents with obesity. Surrogate markers of IS based on fasting insulin have important limitations. The Single-Point Insulin Sensitivity Estimator-Index (SPISE), obtained using the mathematical formula 600 × HDL-C^0.185/Triglycerides^0.2 × BMI^1.338, has been shown to be a predictor for detecting both insulin resistance and the risk of developing g...

hrp0098fc9.2 | Sex Endocrinology and Gonads | ESPE2024

Unveiling DHT-driven Androgen Receptor target genes in genital skin fibroblasts

Sivaprasad Radhika , Händler Kristian , Balachandran Saranya , Caliebe Almuth , Spielmann Malte , Holterhus Paul-Martin , Hornig Nadine

Introduction: The Androgen Receptor (AR) is a steroid hormone receptor. Upon activation by its potent ligand, 5-alpha-dihydrotestosterone (DHT), it regulates the expression of target genes leading to the development of the outer male genitalia. Mutations in the AR gene are associated with Androgen Insensitivity Syndrome (AIS), characterized by the presence of testes and varying degrees of undervirilization of the external genitalia. Since many individ...

hrp0098p2-195 | Growth and Syndromes | ESPE2024

Severe intrauterine growth retardation and diagnosis of growth hormone deficiency as initial presentation of TEMPLE syndrome

Stoeva Iva , Mihova Kalina , Kamenarova Kunka , Kostova Daniela , Georgiev Martin , Ianeva Natasha , Kaneva Radka

Introduction: The first patient with Temple syndrome (TS, ORPHA 254516) was described in 1991. The genetic condition is rare (prevalence<1/1000 000, <100 described patients). An abnormal expression of genes in the imprinted 14q32.2 region has been revealed. The 14.32.2 region is characterized by three differentially methylated regions (DMRs) and a cluster of paternally and maternally expressed genes. Main clinical features are growth delay (pre-and postn...

hrp0098p3-48 | Diabetes and Insulin | ESPE2024

Influence of the Bacillus Calmette-Guérin vaccine on the incidence of cases of type 1 diabetes mellitus in children and adolescents in the Basque Country (last CCAA to withdraw vaccination in Spain)

Diez-Lopez Ignacio , Maeso Mendez Sandra , Gago Martin Ruth , Angel Ogueta Lana Miguel

Type 1 diabetes mellitus is a chronic disease of autoimmune etiology that is highly prevalent in childhood. In the last decade, the possibility of using the Bacillus Calmette-Guérin vaccine for the treatment of this disease has been studied thanks to its immunomodulatory action. These authors published a few years ago an inconclusive work on the influence of the use of BCG on the number of cases observed in the CCAA in a smaller cohort (Bol S Vasco- Nav Pediatrician 202...

hrp0092mte1 | Holistic Approach to the Individual with DSD | ESPE2019

Holistic Approach to the Individual with DSD

Cools Martine

Management of DSD is a sensitive area within the field of paediatric endocrinology. On the one hand, major progress has been made in amongst others understanding the molecular genetic background and the germ cell cancer risk of certain DSD conditions. On the other hand, practices that were common in the past, such as early genital surgery have become strongly criticised and controversial nowadays, leaving clinicians as well as patients and their families with a lot of question...

hrp0092p1-51 | Fat, Metabolism and Obesity | ESPE2019

Pathogenic Mutations and Variants in KSR2 in a Cohort of Obese Children

Körber Ingrid , Sowada Nadine , Schirmer Melanie , Herrmann Gloria , Nunziata Adriana , Bald Martin , Ehehalt Stefan , Paetow Ulrich , Ohlenschläger Ute , Rabenstein Hannah , Siebert Reiner , von Schnurbein Julia , Wabitsch Martin

Background: Kinase suppressor of Ras 2 (KSR2) gene codes for a scaffold protein modulating intracellular pathways that involve MEK/BRAF cascade and AMPK signaling. KSR2 plays an important role in energy balance regulation, and KSR2 mutations were reported to be associated with obesity and insulin resistance in mice and humans. In transfected cells, several KSR2 mutations lead to impaired fatty acid oxidation, which improved under met...